ArticleBone marrow transplantation2017

Idarubicin-intensified haploidentical HSCT with GvHD prophylaxis of ATG and basiliximab provides comparable results to sibling donors in high-risk acute leukemia.

R Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.